NANOSCOPE THERAPEUTICS
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.
NANOSCOPE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Bedford, Texas, United States
Country:
United States
Website Url:
http://www.nanostherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
817-719-2692
Total Funding:
3.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Employees Featured
Samarendra Mohanty Co-Founder & President @ Nanoscope Therapeutics
Co-Founder & President
2021-06-01
Sulagna Bhattacharya Co-Founder & CEO @ Nanoscope Therapeutics
Co-Founder & CEO
Michael Marquez CFO @ Nanoscope Therapeutics
CFO
2022-06-01
Al Guillem Chairman of the Board @ Nanoscope Therapeutics
Chairman of the Board
Aaron Osborne Chief Medical Officer & Chief Development Officer @ Nanoscope Therapeutics
Chief Medical Officer & Chief Development Officer
2022-04-01
Founder
Investors List
National Institutes of Health (NIH)
National Institutes of Health (NIH) investment in Grant - Nanoscope Therapeutics
Key Employee Changes
Official Site Inspections
http://www.nanostherapeutics.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K
- Host name: 83.195.62.50.host.secureserver.net
- IP address: 50.62.195.83
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Nanoscope Therapeutics"
About - Nanoscope Therapeutics
Nanoscope Therapeutics is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other …See details»
Nanoscope Therapeutics Inc. - LinkedIn
Learn more about us at nanostherapeutics.com Nanoscope Therapeutics Inc. Sulagna Bhattacharya, Samarendra Mohanty, Samuel B Barone, Raymond Kaczmarek, Naj Sharif, Glenn Sblendorio, Sunil Gupta, MD ...See details»
Nanoscope Therapeutics Continues Leadership Growth; Welcomes ...
Dec 4, 2023 Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board New Addition …See details»
Nanoscope Therapeutics - Crunchbase Company …
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.See details»
Nanoscope Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Nanoscope Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Nanoscope Therapeutics - VentureRadar
"Nanoscope Therapeutics is a clinical-stage biopharmaceutical company developing gene therapies to cure genetic diseases that cause vision impairment and blindness. These …See details»
Overview, News & Similar companies - ZoomInfo.com
Dec 4, 2023 View Nanoscope Therapeutics (www.nanostherapeutics.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well …See details»
Nanoscope Therapeutics Inc. - Company Profile & Staff Directory ...
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal …See details»
Nanoscope Therapeutics CEO Sulagna Bhattacharya Elected to BIO …
DALLAS, Feb. 17, 2022 — Nanoscope Therapeutics Inc., a late clinical-stage ocular gene therapy company, today announced the election of CEO Sulagna Bhattacharya to the Biotechnology …See details»
Nanoscope Therapeutics Inc. Overview - SignalHire
Nanoscope Therapeutics Inc. is a private company that has been in the industry for 16 years. The company currently specializes in the Biotechnology areaSee details»
Nanoscope Therapeutics Continues Leadership Growth; Welcomes ...
Dec 4, 2023 New Addition Highlights Continued Enhancement of Organization's Strategic Trajectory DALLAS, Dec. 4, 2023 /PRNewswire/ -- Nanoscope Therapeutics (Nanoscope), a …See details»
Nanoscope Therapeutics Licenses Optogenetic CatCh Technology
Sep 30, 2024 Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and geographic atrophy secondary to …See details»
Ray Kaczmarek Joins Nanoscope as Chief Technical and …
Dec 5, 2024 Mr. Kaczmarek has an extensive background of executive leadership and operational expertise in the gene therapy manufacturing industry. Most recently, he served as …See details»
Nanoscope Therapeutics Licenses Optogenetic Technology
Sep 30, 2024 The US biotech company Nanoscope Therapeutics Inc. has acquired a license for the CatCh technology from Max Planck Innovation, the technology transfer organization of the …See details»
ARVO 2023: Samarendra Mohanty PhD - Macular Degeneration …
Nov 12, 2023 Samarendra Mohanty, Ph. D President and Founder Nanoscope Technologies https://nanostherapeutics.com (817) 857-1186 Presentation: Using multi characteristic opsin …See details»
Nanoscope Therapeutics Licenses Optogenetic CatCh Technology
DALLAS, Sept. 30, 2024 — Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and geographic atrophy …See details»
Nanos Leadership | Transforming Drug Delivery Through …
The nanos team aims to transform drug delivery through nanotechnology. Our team of proven healthcare executives has experience in a variety of drug delivery methods.See details»
Nanoscope Therapeutics Continues Leadership Growth; Welcomes ...
Dec 4, 2023 Nanoscope Therapeutics (Nanoscope), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced the appointment of …See details»
Nanoscope Therapeutics Announces Presentations at Upcoming …
Feb 4, 2025 MCO-010 has received FDA Fast Track designations and FDA orphan drug designations for both RP and Stargardt. Preclinical programs include an IND-ready non-viral …See details»
DNA-LNPs: A Safer, Longer-Lasting Gene Therapy Breakthrough
4 days ago Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, …See details»